M Cheung
Overview
Explore the profile of M Cheung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
74
Citations
865
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barker S, Maguire N, Gearing R, Cheung M, Price D, Narendorf S, et al.
SSM Popul Health
. 2021 Sep;
15:100905.
PMID: 34568536
In the US, many people are excluded from healthcare structures and systems, due to multiple macro and micro factors. Poverty, health ecosystems, mental health, and community amenities are some of...
2.
Bhella S, Varela N, Aw A, Bredeson C, Cheung M, Crump M, et al.
Curr Oncol
. 2020 Dec;
27(6):e632-e644.
PMID: 33380879
Background: In Ontario, no clearly defined standard of care for the management of mantle cell lymphoma (mcl) has been developed, and substantial variability from centre to centre is evident. This...
3.
Chan C, Cheung M, Tsui M
Hong Kong Med J
. 2020 Jun;
26(3):273-274.
PMID: 32554821
No abstract available.
4.
OBrien C, Healy G, Anglim B, OBrien A, Duignan J, Patel A, et al.
Ir Med J
. 2019 Oct;
112(7):968.
PMID: 31642642
Aim
We will review our experience of emergent arterial embolization used to treat haemodynamically unstable patients
with obstetric and gynaecological haemorrhage.
Methods
This is a retrospective study of patients with...
5.
Cheung W, Kornelsen E, Mittmann N, Leighl N, Cheung M, Chan K, et al.
Curr Oncol
. 2019 May;
26(2):89-93.
PMID: 31043808
Background: Economic evaluations are an integral component of many clinical trials. Costs used in those analyses are based on the prices of branded drugs when they first enter the market....
6.
Patterns and Drivers of Costs for Neuroendocrine Tumor Care: A Comparative Population-Based Analysis
Hallet J, Law C, Cheung M, Mittmann N, Liu N, Fischer H, et al.
Ann Surg Oncol
. 2017 Jul;
24(11):3312-3323.
PMID: 28695392
Background: Little is known about resource use in the care of neuroendocrine tumors (NETs). This study defined patterns of costs in NET management and compared them with those of a...
7.
Sussman J, Varela N, Cheung M, Hicks L, Kraftcheck D, Mandel J, et al.
Curr Oncol
. 2016 Nov;
23(5):e499-e513.
PMID: 27803611
Objective: This evidence summary set out to assess the available evidence about the follow-up of asymptomatic survivors of lymphoma who have received curative-intent treatment. Methods: The medline and embase databases...
8.
Prica A, Baldassarre F, Hicks L, Imrie K, Kouroukis T, Cheung M
Clin Oncol (R Coll Radiol)
. 2016 Oct;
29(1):e13-e28.
PMID: 27746042
Rituximab is the first monoclonal antibody to be approved for use by the US Food and Drug Administration in cancer. Its role in the treatment of non-Hodgkin lymphoma, including chronic...
9.
McCloskey K, Ponsonby A, Collier F, Allen K, Tang M, Carlin J, et al.
Pediatr Obes
. 2016 Oct;
13(1):46-53.
PMID: 27723247
Background: Excess adiposity and adiposity-related inflammation are known risk factors for cardiovascular disease in adults; however, little is known regarding the determinants of adiposity-related inflammation at birth. Objectives: The aim...
10.
Cheung M, Seres T, Cleveland J, Kounis N
Int J Cardiol
. 2016 May;
218:267-268.
PMID: 27236126
No abstract available.